Tandem Diabetes Care (NSDQ:TNDM) this week announced that it won FDA clearance for its Basal-IQ technology for interoperable automated glycemic control (iAGC). The FDA has only classified three categories for the interoperability of devices as a complete automated insulin dosing (AID) system, an integrated continuous glucose monitoring and an iAGC. “Aligning Basal-IQ technology with Control-IQ technology […]
Diabetes
Welcome to MassDevice's Diabetes Hub, your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Here are top diabetes features from MassDevice and its sister publications (and scroll down to read the latest diabetes device news from MassDevice):
+ These diabetes devices are set to launch in 2024
+ The top IVD and diabetes tech stories of 2023
+ How Dexcom designed a new “life-changing” sensor for even more people with diabetes
+ Embecta CEO sees GLP-1 opportunities as company progresses on insulin patch pump
+ The 10 biggest diabetes tech stories from 2023
Latest Diabetes News
Companion Medical wins FDA nod for InPen diabetes management system
Companion Medical announced that it won FDA clearance for its InPen bolus calculator for fixed dosing and meal estimation in diabetes management. The new bolus calculator is designed to account for the user’s current glucose level and active insulin to remove the guesswork from insulin dosing. Companion Medical touts the system as the first of its […]
Insulet down after hours on Q4 sales beat, bottom-line slide
Insulet (NSDQ:PODD) shares took a further hit today after sliding in the market following the release of the company’s quarterly earnings. The company’s shares sunk after-hours yesterday on fourth-quarter results that beat the consensus forecast for revenue but appeared to miss on earnings. Today, shares of PODD are down -8.4% at $180.18 per share in mid-afternoon […]
Dexcom lands CE Mark for continuous glucose monitor use by pregnant women
Dexcom (NSDQ:DXCM) said Friday that its G6 continuous glucose monitor system has received the CE Mark for use during pregnancy, and will be available soon, starting with the United Kingdom in Spring 2020. Glucose levels are hard to manage in pregnancy due to the increasing need for and resistance to insulin. Poorly controlled glucose levels in […]
Abbott touts real-world data around FreeStyle Libre system
Abbott (NYSE:ABT) recently announced that new real-world data shows that users of its FreeStyle Libre continuous glucose monitor (CGM) have improved on four different fronts. Users of the Abbott Park, Ill.–based company’s device showed better glucose control, increased time in target glucose range, decreased time in hyperglycemia and hypoglycemia and reduced HbA1C (average glucose levels over […]
Insulet partners with Abbott and Dexcom on automated insulin delivery
Abbott (NYSE:ABT) and Dexcom (NSDQ:DXCM) each announced today that they are partnering with Insulet (NSDQ:PODD) to feed blood glucose monitor data into an automated insulin delivery system. For Acton, Mass.–based Insulet, the agreements are a boost for its next-generation Omnipod Horizon automated insulin delivery system, which is presently an investigational device in the United States. The idea of […]
Dexcom skyrockets on Street-beating Q4
Dexcom (NSDQ:DXCM) shares took a big jump up today on fourth-quarter results that topped the consensus forecast with relative ease and improved upon losses from the company’s previous fourth quarter. Shares of DXCM were up 13.8% at $286.96 per share in late-morning trading today. The San Diego–based continuous glucose monitor maker posted profits of $92.7 million, […]
Blood glucose monitor company One Drop expands team
One Drop announced today that it added former Sanofi executive Rachel Yap Martens and former ResMed executive Gina Merchant to its executive team. Yap Martens is set to become One Drop’s senior VP of consumer solutions and commercial strategy, having previously served as Sanofi’s head of U.S. diabetes integrated care. Martens’ new role includes attempting […]
Insulet’s Omnipod Dash Personal Diabetes Managers have a glitch
Insulet (NSDQ:PODD) is issuing a voluntary medical device correction for all of the smartphone-like Personal Diabetes Managers that came with its next-gen Omnipod Dash insulin management system, the company announced today. During its ongoing quality management process, Insulet officials discovered that the PDMs on rare occasions will suggest an inaccurate bolus amount based on a blood […]
Wearable insulin delivery device maker Valeritas files for Chapter 11, selling company
Valeritas (NSDQ:VLRX) announced that the company and its subsidiaries filed voluntary petitions for Chapter 11 bankruptcy, having agreed to sell substantially all of the business to Zealand Pharma (CPH:ZEAL). The agreement is slated to provide a total cash consideration of $23 million along with certain liabilities related to the ongoing business. Once the acquisition is completed, Zealand […]
FDA says Medtronic MiniMed insulin pump recall is serious
The U.S. FDA has designated a recall of hundreds of thousands of Medtronic Minimed insulin pumps as Class I — the most serious type of recall. Medtronic (NYSE:MDT) first warned of safety problems with the pumps in November. The recall involves 322,005 pumps — MiniMed 630G (model MMT-1715) and MiniMed 670G (model MMT-1780) — in the […]